Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Piperacillin × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Cyclophosphamide 72 fludarabine phosphate 66 Whole-Body Irradiation 48 Busulfan 46 Mycophenolic Acid 45 Cyclosporine 44 Peripheral Blood Stem Cell Transplantation 40 fludarabine 38 Melphalan 33 Antilymphocyte Serum 30 Tacrolimus 29 Filgrastim 25 Cord Blood Stem Cell Transplantation 25 Radiotherapy 20 Cytarabine 20 Methotrexate 19 Methylprednisolone 17 Granulocyte Colony-Stimulating Factor 16 apixaban 14 Thiotepa 14 Dalteparin 12 Alemtuzumab 12 thymoglobulin 11 Rivaroxaban 11 ferric carboxymaltose 10 eltrombopag 10 Surveys and Questionnaires 10 Cyclosporins 10 Etoposide 9 Epoetin Alfa 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡